Cite
HARVARD Citation
Elger, C. et al. (2017). Pooled efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Data from four double‐blind placebo‐controlled pivotal phase III clinical studies. CNS neuroscience & therapeutics. pp. 961-972. [Online].